Abstract
Objectives: This study describes the distribution of dystroglycan (DG) in human placenta, membranes, and uterine decidua. Study design: Dystroglycan expression was characterized by Western blotting, immunohistochemistry, and immunofluorescence microscopy using human tissues and cultured cells. Results: Both α-DG and β-DG are expressed in the term syncytiotrophoblast, and α-DG is localized to the basement membrane. In first-trimester chorionic villi, α-DG and β-DG are localized to the periphery of the cytotrophoblast. Expression varies in term fetal membranes. α-Dystroglycan is not detectable in choriocarcinoma cells or HTR cells, but β-DG is present in both normal and cleaved forms. Conclusion: Dystroglycan is expressed at high levels in human trophoblasts, and localization of the α- and β-subunits varies with gestational age and trophoblast differentiation. Because DG expression inversely correlates with invasiveness in many cancers, its pattern of expression in trophoblasts suggests a possible function in inhibition of placental invasion. © The Author(s) 2012.
Author supplied keywords
Cite
CITATION STYLE
Street, R. M., Mucowski, S. J., Urrabaz-Garza, R., O’Boyle, K., Snyder, R. R., & Theiler, R. N. (2012). Dystroglycan expression in human placenta: Basement membrane localization and subunit distribution change between the first and third trimester. Reproductive Sciences, 19(3), 282–289. https://doi.org/10.1177/1933719111419247
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.